Viking Therapeutics, Inc. (VKTX): A Bull Case Theory

We came across a bullish thesis on Viking Therapeutics, Inc.  on r/wallstreetbets subreddit by Dritzz-9966. In this article, we will summarize the bulls’ thesis on VKTX. Viking Therapeutics, Inc. 's share was trading at $32.07 as of July 17^th.

Viking Therapeutics (VKTX), a ~$3.45B biotech firm, is flying under the radar despite its potentially transformative role in the obesity treatment market. The investment thesis centers on VK2735, a GLP-1/GIP dual agonist for weight loss, being developed in both subcutaneous (Phase 3) and oral (Phase 2) forms—mirroring the mechanism of Eli...